Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L K Gilliland

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cellsL K Gilliland, M R Clark, H Waldmann
Seminars in Immunology|March 1, 1990
The interaction of CD4 with CD3/Ti regulates tyrosine phosphorylation of substrates during T cell activationJ A Ledbetter, L K Gilliland, G L Schieven
Current Opinion in Immunology|April 1, 1997
Antibody engineeringM S Hayden, L K Gilliland, J A Ledbetter
Tissue Antigens|March 1, 1990
CD45 ligation in T cells regulates signal transduction through both the interleukin-2 receptor and the CD3/Ti T-cell receptor complexL K Gilliland, G L Schieven, L S Grosmaire, et al.
Molecular Biology of the Cell|May 1, 1993
Ultraviolet radiation rapidly induces tyrosine phosphorylation and calcium signaling in lymphocytesG L Schieven, J M Kirihara, L K Gilliland, et al.
Human Immunology|August 1, 1989
Signal transduction in lymphocyte activation through crosslinking of HLA class I moleculesL K Gilliland, N A Norris, L S Grosmaire, et al.
The Journal of Biological Chemistry|July 5, 1992
Lymphocyte lineage-restricted tyrosine-phosphorylated proteins that bind PLC gamma 1 SH2 domainsL K Gilliland, G L Schieven, N A Norris, et al.
Cancer Research|July 15, 1995
Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigenJ A Francisco, L K Gilliland, M R Stebbins, et al.
The EMBO Journal|July 1, 1993
Tyrosine phosphorylation of CD19 in pre-B and mature B cellsN J Chalupny, S B Kanner, G L Schieven, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Elimination of the immunogenicity of therapeutic antibodiesL K Gilliland, L A Walsh, M R Frewin, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cellsL K Gilliland, M R Clark, H Waldmann
Seminars in Immunology|March 1, 1990
The interaction of CD4 with CD3/Ti regulates tyrosine phosphorylation of substrates during T cell activationJ A Ledbetter, L K Gilliland, G L Schieven
Current Opinion in Immunology|April 1, 1997
Antibody engineeringM S Hayden, L K Gilliland, J A Ledbetter
Tissue Antigens|March 1, 1990
CD45 ligation in T cells regulates signal transduction through both the interleukin-2 receptor and the CD3/Ti T-cell receptor complexL K Gilliland, G L Schieven, L S Grosmaire, et al.
Molecular Biology of the Cell|May 1, 1993
Ultraviolet radiation rapidly induces tyrosine phosphorylation and calcium signaling in lymphocytesG L Schieven, J M Kirihara, L K Gilliland, et al.
Human Immunology|August 1, 1989
Signal transduction in lymphocyte activation through crosslinking of HLA class I moleculesL K Gilliland, N A Norris, L S Grosmaire, et al.
The Journal of Biological Chemistry|July 5, 1992
Lymphocyte lineage-restricted tyrosine-phosphorylated proteins that bind PLC gamma 1 SH2 domainsL K Gilliland, G L Schieven, N A Norris, et al.
Cancer Research|July 15, 1995
Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigenJ A Francisco, L K Gilliland, M R Stebbins, et al.
The EMBO Journal|July 1, 1993
Tyrosine phosphorylation of CD19 in pre-B and mature B cellsN J Chalupny, S B Kanner, G L Schieven, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Elimination of the immunogenicity of therapeutic antibodiesL K Gilliland, L A Walsh, M R Frewin, et al.
Pageof 3